FILTER

FILTERED ARTICLE RESULTS

The Winning Formula: Building the Number One Biopharmaceutical Supercluster

February 22, 2018
Massachusetts offers perhaps the most attractive environment for biopharmaceutical research and development in the world, and is fast closing the gap with its rival supercluster in California.

Quality: A Means for Value Creation

June 19, 2017
Firms must shift focus from Quality for Compliance to Quality as a Culture by keeping the end patient in mind.

Regulating Quality

June 19, 2017
Maintaining Safeguards Whilst Lowering Barriers to Market Entry.

Innovation: The Industry’s Backbone

May 24, 2017
The cost of developing new drugs and cures is enormous. A delicate balance between encouraging innovation and controlling the cost of medicines has to be maintained.

Logistics and Distribution: From Factory to Patient

May 09, 2017
Consolidation and the requirements of new and personalized drugs are changing the playing field.

Paying the Price: U.S. Biopharma Industry

March 17, 2017
Slashing drug prices might benefit patients in the short term, but at what cost?

Pooling Its Force: U.S. Biopharmaceutical Industry Channels R&D Focus Amid Changing Tides

March 01, 2017
In a time of uncertainty across the board, the United States is still "going boldly” ahead, bringing us innovation and constantly adapting its business model.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Mexico Chemicals 2024

In August 2023, Mexican exports to the US surpassed China for the first time. As companies prioritize securing supply their chains after years of logistics challenges, Mexico has begun to see major benefits. With a spate of new infrastructure projects such as the Interoceanic Corridor of the Isthmus of Tehuantepec coming online in 2023, the country is actively opening itself to investment. The chemical industry, in particular, is positioned for nearshoring-driven growth.

PARTNER EVENTS